CD4 and cancer: We noticed that SLC12A5 expression was distinctly correlated with the level of immune infiltration of B cells in 15 types of cancers, CD8+ T cells in 10 types of cancers, CD4+ T cells in 22 types of cancers, and macrophages in 16 types of cancers (Supplementary Figure S1 and S2).